Dr. Michael Dan
Chief Executive Officer
Gemini Power Corp. & Regulus Investments Inc.
Michael has a diverse background that includes neurosurgery, medical research, biotechnology, and portfolio management. After five years as an Assistant Professor of Neurosurgery at LSU School of Medicine, New Orleans, Michael left medicine to become the CEO of Novopharm Biotech, an early phase, publicly traded, drug discovery company. He is currently President of Regulus Investments Inc. and Gemini Power Corp. He is also a trustee of the Paloma Foundation and a member of the Board of Directors of the Canadian Friends of Haifa University.
Michael holds an MD degree from The University of Toronto; a PhD in Experimental Medicine from McGill University; and, an MBA from Tulane University. He is a Fellow of The Royal College of Physicians and Surgeons of Canada, and a Diplomate of the American Board of Neurological Surgeons.